Medicinal Product Shortages – update – 16 February 2022

Notice type: Advisory

Date: 16/02/2022

 

Further Information:

 The Health Products Regulatory Authority has been notified of a shortage of the following products:

  • Ciprofloxacin 2mg/ml Solution for Infusion (100ml presentation only) - PA1122/005/001
  • Dalacin T Topical Lotion 10mg/ml Cutaneous Emulsion - PA0822/121/001
  • Hyaluronidase 1500 IU Powder for Solution for Injection or Infusion - PA0281/231/001
  • Innohep 10,000 IU/ml Solution for Injection - PA0046/060/002
  • Innohep 12,000 IU in 0.6ml, Solution for Injection - PA0046/060/013
  • MST Continus 5mg Prolonged Release Tablets - PA1688/004/001
  • Opticrom Allergy Single Dose 2% w/v Eye Drops, Solution - PA23180/010/003
  • Prasugrel 10mg Film Coated Tablets - EU/1/18/1273/002
  • Prednisolone 20mg Rectal Foam - PA22643/003/001
  • Salamol Steri-Neb 2.5mg/2.5ml Nebuliser Solution - PA1986/086/001
  • Technescan MIBI 1mg Kit for Radiopharmaceutical Preparation - PA0690/020/001
  • Uniphyllin Continus 400mg Prolonged Release Tablets - PA1688/011/003

 

The following shortages have been resolved and supply has resumed to the Irish market:

  • Co-Amoxiclav Teva 1000mg/200mg Powder for Solution for Injection/Infusion - PA0749/011/002
  • Denzapine 50mg/ml Oral Suspension - PA0126/235/005
  • Fexofenadine Hydrochloride 180mg Film Coated Tablets - PA22871/004/003
  • Letrozole Mylan 2.5mg Film Coated Tablets - PA0577/116/001
  • Mirap 45mg Tablet - PA0711/062/003
  • Mydrilate 0.5% Eye Drops - PA22709/003/001
  • Nebivolol Teva 5mg Tablets - PA0749/078/001
  • Osteomel Once Weekly 70mg Tablets - PA0126/148/002
  • OxyNorm Dispersa 10mg Orodispersible Tablets - PA1688/006/008
  • Pinamox 125mg/5ml Powder for Oral Suspension - PA0298/010/001
  • Rosuvastatin 5mg Film Coated Tablets - PA2315/068/001
  • Rosuvastatin 40mg Film Coated Tablets - PA2315/068/004
  • Stesolid Rectal Solution 5mg - PA2315/137/001
  • Stesolid Rectal Solution 10mg - PA2315/137/002
  • Xarelto 1mg/ml Granules for Oral Suspension - EU/1/08/472/050-051
  • Xylocaine 10mg/Delivered Dose Mucosal Spray - PA1691/028/001

 

Please see the shortages section of the HPRA website for further information.

The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.




« Back